Abstract
Traditional medicines are widely recognized and used as therapeutic agents such as anti-inflammatory, cough remedies, antipyretic, etc. The myth with public concerning traditional medicine is that it is safe to consume as it has been bestowed by our forefathers and it can be consumed without prescription which have led to self-medication which in turn often led to disappointing side effects and end results. There is alarming need for increasing awareness to develop pharmacovigilance practices with regard to herbal and traditional medicines. The present status of pharmacovigilance and its tools have been developed in relation to drugs which are synthetic in nature. With recent several prominent drugs withdrawn from the market, the pharmaceutical agencies have raised the issue of pharmacovigilance. Early uncovering of signals from clinical and pharmacovigilance studies has now been adapted by main companies in order to detect and identify the association of risk with medicinal products and to effectively manage the risk by applying health hazard management plans during the life cycle of the product. Applying the methods to monitor the safety of traditional medicine is an exclusive challenge. A strong, well-defined system for monitoring adverse events is in a position for evaluating the safety of the drugs. In today’s world, there is an immense need to understand and implement pharmacovigilance with more activity of clinical research conducted all over the globe.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bass IS, Raubicheck CJ (2000) Marketing dietary supplements. Food and Drug Law Institute, Washington DC
Berner M, Kriston L, Linde K et al (2008) St John’s wort for major depression. Cochrane Database Syst Rev 4:CD000448
Boullata JI, Nace AM (2000) Safety issues with herbal medicine. Pharmacotherapy 20:257–269. https://doi.org/10.1592/phco.20.4.257.34886
Bowdler J (1997) Effective communications in pharmacovigilance. The Erice report. Birmingham
Dasgupta A (2003) Review of abnormal laboratory test results and toxic effects due to use of herbal medicines. Am J Clin Pathol 120(1):127–137
Elvin-Lewis M (2001) Should we be concerned about herbal remedies. J Ethnopharmacol 75:141–164
Ernst E (2002) Toxic heavy metals and undeclared drugs in Asian herbal medicines. Trends Pharmacol Sci 23:136–139
Gadre GK (1910) AshtangHridaya. 13thAdhyaya, 2nd edn. Aryabhushan Printing Press, Pune, p 65
Gogtay NJ, Bhatt HA, Dalvi SS, Kshirsagar NA et al (2002) The use and safety of non-allopathic Indian medicines. Drug Saf 25:1005–1019
Jawadekar YM, Shah KN, Kshirsagar NA et al (1992) A study of phenobarbital and dilantin in neonatal seizures. Indian J Pediatr 59:729. https://doi.org/10.1007/BF02859409
Jerosch J (2011) Effects of glucosamine and chondroitin Sulfate on cartilage metabolism in OA: outlook on other nutrient partners especially Omega-3 fatty acids. Int J Rheumatol 2011:Article ID 969012. https://doi.org/10.1155/2011/969012
Khan RA, Latif A, Rahman SZ et al (2008) Importance of pharmacovigilance in Unani system of medicine. Indian J Pharmacol 40(Suppl SI):17–20
Kinsel JF, Straus SE (2003) Complementary and alternative therapeutics: rigorous research is needed to support claims. Annu Rev Pharmacol Toxicol 43:463–484
Kubde S (2016) Adverse drug reactions and pharmacovigilance of herbal medicines in India. IJGP 10(1)
Mann RD, Andrews EF (eds) (2002) Pharmacovigilance. Wiley, Chichester
Nyambega RG, Sharma PK, Dutta S et al (2018) Need of PV in Ayurvedic medicines. Int J Green Pharm 12(1):S21
Pittler MH, Ernst E (2012) Horse chestnut seed extract for chronic venous insufficiency. Cochrane Database Syst Rev 11:CD003230. https://doi.org/10.1002/14651858.CD003230
Prabhu MS, Platel K, Saraswati G, Srinivasan K et al (1995) Effect of orally administered betel leaf (Piper betle Linn.) on digestive enzymes of pancreas and intestinal mucosa and on bile production in rats. Indian J Exp Biol 33(10):752–756
Shastri PK (1994) Rasantarangini. 2nd Adhyaya, 11th edn. Sri Jainendra Press, New Delhi, pp 22–24
Shetti S, Kumar CD, Sriwastava NK, Sharma IP (2011) Pharmacovigilance of herbal medicines: current state and future directions. Pharmacogn Mag 7(25):69–73
Sugimoto K, Ohmori M, Tsuruoka S, Nishiki K et al (2001) Different effects of St John’s wort on the pharmacokinetics of simvastatin and pravastatin. Clin Pharmacol Ther 70(6):518–524
The Council for International Organizations of Medical Sciences (2001) Current challenges in pharmacovigilance: pragmatic approaches. The Council for International Organizations of Medical Sciences, Geneva. https://cioms.ch. Accessed 3 Nov 2019
Trikramji AJ (2001) CharakSamhita. 8th Adhyaya, 5th edn. Chaukhambha Sanskrit Sansthan, Varanasi, p 276
Tuffs A (2002) Three out of four Germans have used complementary or natural remedies. Br Med J 325:990
Wal P, Wal A, Gupta S et al (2011) Pharmacovigilance of herbal products in India. J Young Pharm 3:256–258
WHO (2000) General guidelines for methodologies on research and evaluation of traditional medicine. World Health Organization, Geneva. https://apps.who.int. Accessed 27 Dec 2019
WHO (2002) The importance of pharmacovigilance—safety monitoring of medicinal products. World Health Organization, Geneva. https://apps.who.int. Accessed 28 Dec 2019
WHO (2003) WHO guidelines on good agricultural and collection practices (GACP) for medicinal plants. World Health Organization, Geneva. https://apps.who.int. Accessed 28 Dec 2019
WHO (2004a) Guidelines on developing consumer information on proper use of traditional, complementary and alternative medicine. World Health Organization, Geneva. http://apps.who.int/medicinedocs. Accessed 28 Dec 2019
WHO (2004b) WHO guidelines on safety monitoring of herbal medicines in pharmacovigilance systems. World Health Organization, Geneva. https://apps.who.int. Accessed 27 Dec 2019
WHO (2017) Pharmacovigilance for traditional medicine products: why and how? World Health Organization, Southeast Asia. https://apps.who.int. Accessed 16 Dec 2019
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Golmei, P., Kalita, P., Agrawal, S.S., Ahmed, A.B., Sen, S., Chakraborty, R. (2021). Pharmacovigilance: Methods in Developing the Safety and Acceptability of Traditional Medicines. In: Mandal, S.C., Chakraborty, R., Sen, S. (eds) Evidence Based Validation of Traditional Medicines. Springer, Singapore. https://doi.org/10.1007/978-981-15-8127-4_34
Download citation
DOI: https://doi.org/10.1007/978-981-15-8127-4_34
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-8126-7
Online ISBN: 978-981-15-8127-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)